Dainippon Sumitomo Pharma Acquires Boston Biomedical for $2,630,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f565cfa-590f-4799-9763-c323f10712e5&Preview=1 -
Date
3/2/2012 -
Company Name
Boston Biomedical -
Mailing Address
333 Providence Hwy. Norwood, MA 02062 -
Company Description
Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer. -
Website
http://www.Bostonbiomedical.com -
Transaction Type
M&A -
Transaction Amount
$2,630,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
DSP will acquire BBI for up to $2.63 billion in total which includes $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.
